WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998051795) DOUBLE-STRANDED RNA-BINDING PROTEIN
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/1998/051795 International Application No.: PCT/US1998/009877
Publication Date: 19.11.1998 International Filing Date: 13.05.1998
IPC:
A61K 38/00 (2006.01) ,C07K 14/47 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
46
from vertebrates
47
from mammals
Applicants: HILLMAN, Jennifer, L.[US/US]; US (UsOnly)
LAL, Preeti[IN/US]; US (UsOnly)
CORLEY, Neil, C.[US/US]; US (UsOnly)
INCYTE PHARMACEUTICALS, INC.[US/US]; 3174 Porter Drive Palo Alto, CA 94304, US (AllExceptUS)
Inventors: HILLMAN, Jennifer, L.; US
LAL, Preeti; US
CORLEY, Neil, C.; US
Agent: BILLINGS, Lucy, J.; Incyte Pharmaceuticals, Inc. 3174 Porter Drive Palo Alto, CA 94304, US
Priority Data:
08/855,51813.05.1997US
Title (EN) DOUBLE-STRANDED RNA-BINDING PROTEIN
(FR) PROTEINE FIXATRICE D'ARN DOUBLE BRIN
Abstract:
(EN) The present invention provides a double-stranded RNA-binding protein (BINDR) and polynucleotides which identify and encode BINDR. The invention also provides expression vectors, host cells, agonists, antibodies, and antagonists. The invention also provides methods for treating disorders associated with expression of BINDR.
(FR) La présente invention concerne une protéine fixatrice d'ARN double brin (BINDR) et des polynucléotides identifiant et codant pour BINDR. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des agonistes, des anticorps et des antagonistes. L'invention concerne également des méthodes permettant de traiter des troubles associés à l'expression de BINDR.
Designated States: AT, AU, BR, CA, CH, CN, DE, DK, ES, FI, GB, IL, JP, KR, MX, NO, NZ, RU, SE, SG, US
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)